Newsroom
-
Vertex signs another Mammoth-sized CRISPR deal with $650M in biobucks on the line
Fierce BiotechLearn More -
UPDATED: Jennifer Doudna spinout inks a Mammoth CRISPR deal with Vertex worth nearly $700M
Endpoints NewsLearn More -
Vertex and Mammoth Biosciences Announce Collaboration to Develop In Vivo Gene-Editing Therapies for Serious Diseases
Business WireLearn More -
Breakout “CRISPR platform” company Mammoth Biosciences is officially a unicorn
TechCrunchLearn More -
Mammoth Biosciences raises $195 million vaulting its CRISPR tech to unicorn status
ForbesLearn More -
Jennifer Doudna’s diagnostic spinout raises Mammoth round as it expands to therapies
Endpoints NewsLearn More -